Effect of protease inhibitors and substrates on deoxycorticosterone binding to its receptor in dog MDCK kidney cells.
D001667:Binding, Competitive; D002460:Cell Line; D003900:Desoxycorticosterone / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D007700:Kinetics; D010664:Phenylmethylsulfonyl Fluoride / Q000494:pharmacology; D011480:Protease Inhibitors; D011987:Receptors, Steroid / Q000187:drug effects*; D014106:Tosylarginine Methyl Ester / Q000494:pharmacology; D014107:Tosyllysine Chloromethyl Ketone / Q000494:pharmacology; D014108:Tosylphenylalanyl Chloromethyl Ketone / Q000494:pharmacology
D004791:Enzyme Inhibitors; D011480:Protease Inhibitors; D011987:Receptors, Steroid; D014107:Tosyllysine Chloromethyl Ketone; D014108:Tosylphenylalanyl Chloromethyl Ketone; D003900:Desoxycorticosterone; D010664:Phenylmethylsulfonyl Fluoride; D014106:Tosylarginine Methyl Ester